WuXi PharmaTech (Cayman) Inc. Capital Expenditures
WuXi PharmaTech (Cayman) Inc. reported Capital Expenditures of $98.14 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2015-04-15
| Period end | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|
| 2014-12-31 | $98.14M 20-F · filed 2015-04-15 |
| 2013-12-31 | $53.43M 20-F · filed 2015-04-15 |
| 2012-12-31 | $66.87M 20-F · filed 2015-04-15 |
| 2011-12-31 | $63.41M 20-F · filed 2014-04-15 |
| 2010-12-31 | $48.88M 20-F · filed 2013-04-17 |
| 2009-12-31 | $54.99M 20-F · filed 2012-04-20 |
| 2008-12-31 | $63.25M 20-F · filed 2011-04-27 |